ClinicalTrials.gov
ClinicalTrials.gov Menu

Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer (TIME 2 CHANGE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00884143
Recruitment Status : Completed
First Posted : April 20, 2009
Last Update Posted : April 20, 2010
Sponsor:
Information provided by:
AstraZeneca

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2010
  Actual Study Completion Date : January 2010